Pharma Mar, S.A. (PHMMF) has a profit margin of 25.7%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for PHMMF is 25.7% as of June 2026. That compares with 22.2% in the prior-year period — up 15.8% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Pharma Mar, S.A.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, PHMMF's profit margin moved from 22.2% to 25.7% — a 15.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pharma Mar, S.A.'s valuation or profitability profile.
Against Healthcare companies, PHMMF currently prints 25.7% for profit margin, while the sector average sits near 17.63%. That is roughly 45.8% above the sector mean. Large gaps often invite a closer look at Pharma Mar, S.A.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Pharma Mar, S.A. converts resources into returns. At 25.7%, PHMMF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 22.2% in the prior-year period — up 15.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PHMMF's profit margin (25.7%), review year-over-year change from 22.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.